DevelRx will be participating in the 87th Annual Scientific meeting of the College on Problems of Drug Dependence (CPDD) to be held at The Sheraton New Orleans Hotel, New Orleans, Louisiana, USA, 14th to 18th June 2025. We have two oral presentations:
Framework Proposals for the Abuse Potential Assessment and Scheduling of Classical and Novel Psychedelic Drugs. David Heal, Jane Gosden, Sharon Smith. In ‘Possible Futures: Insights From and Recommendations for Programs and Policies in SUD Research and Treatment Implementation’. Monday 16th June. 1.45 – 3.00 pm.
Comparison of the Pharmacological and Behavioral Profiles of Centanafadine and Methylphenidate – Implications for Safety and Abuse Potential. Sharon Smith, Jane Gosden, David Heal, *Reem Elbekai. *Otsuka Pharmaceutical Development & Commercialization, Inc, USA. In the oral session ‘Where’s my drink? Interactions between SUDs and ADHD’. Tuesday 17th June. 2.30 – 3.30 pm.
David Heal will be at the CPDD and will also be attending the International Study Group Investigating Drugs as Reinforcers (ISGIDAR) meeting at The Sheraton New Orleans Hotel on Saturday 14th June. 8.00 am - 6.00 pm.
If you would like to meet David in New Orleans to explore how DevelRx can support the development of your CNS drug candidates, please get in touch.